Research on the Path of Improving the Technological Innovation Ability of Chinese Pharmaceutical Industry Based on Technology
- 1 China Pharmaceutical University, Nanjing, China
- 2 China Pharmaceutical University, Nanjing, China
Abstract
Based on the perspective of professional knowledge and professional technology, this paper focuses on the path to improve the technological innovation ability on the technical level, and provides advice and reference for promoting the pharmaceutical industry to achieve the improvement of technological innovation ability and the structural upgrading of the entire industry. It is found that in the project approval process of innovation subject, the key is to realize the guiding role of market demand on the project approval process of scientific research. In the research and development of innovative drugs, it is necessary to focus on the adaptation and transformation of laboratory technology in scale-up production. In the process of innovation achievement delivery and transformation, the focus is to truly complete the extension from the patent application stage to the product launch stage.
- Li, F. and Hu, J.F. (2019) Analysis of the Situation and Development Strategies of Research Institutes from the National Key R&D Plan in the Field of Biomedicine from 2016 to 2018. China Medical Biotechnology, 4, 189-192.
- Li, J.G., Guo, H. and Song, J.X. (2021) Selection of Clinical Guidelines and Individualized Medicine for Patients. Medicine and Philosophy, 1, 1-5+80.
- Dai, G.L., Ma, H., Zhang, K., Tong, Y.J. and Hu, H.P. (2022) Research on the Development Status and Countermeasures of Generic Drugs in China. China Medical Sciences, 1, 185-188.
- Zhang, H.L. (2019) Research on Innovation and Development Strategy of Biomedical Industry in China. Jilin University. https://doi.org/10.2991/edmi-19.2019.18
- Yuan, Y.M. (2020) Exploration and Practice of Biomedical Entrepreneurial Talent Training Model Based on School-Enterprise Cooperation. Journal of Higher Education, 11, 45-48.
- An, X.L., Huang, W.Q., Su, Y.N. and Luo, Z. (2022) Research on Risk Control Strategy of Innovative Drug Clinical Trials under New Policy Environment. Gansu Medicine, 1, 66-69.
- Long, X. (2019) Research on Governance Structure of Scientific and Technological Achievements Transformation Platform in Chinese Universities. Beijing Forestry University.
- Zhang, Y.F. and Mao, N.Y. (2020) Analysis on Causes of Difficulties in the Transformation of Medical Science and Technology Achievements in Universities Based on Transaction Cost Theory. Scientific Management Research, 5, 35-41.
- Zhang, Y., Zhu, H. and Han, Y. (2017) Changes of Drug Registration and Approval Management System in China. Heilongjiang Medicine, 12, 1221-1223. https://doi.org/10.22448/AMJ.2017.3.12-12
- Wu, C.Y., Huang, W. and Liu, M.J. (2019) Preliminary Study on Drug Registration Standards. China Pharmaceutical Affairs, 5, 578-581.